We could use a little pick me up during the weeken

We could use a little pick me up during the weekend while we wait for something big to happen . Here is what I ran into while searching for something good to help w the morning bowel movement .

???? A Tiny Dose of CYDY — 48 Days to ESMO
In 2020, CytoDyn chased headlines.
In 2025, it’s chasing a cure.
And no one’s ready for what’s about to drop at ESMO.

Back then, we had hype.
Now?

We’ve got stage 4 breast cancer patients alive 3 years later — and walking into ESMO 2025 with the data to prove it.

What’s different now?

✅ No more Nader. The circus is gone.
✅ No more COVID sideshow. They’re not chasing headlines — they’re running real oncology trials.
✅ No more FDA drama. New cancer trial? FDA-cleared.

And the data?

Let’s just say it blows Trodelvy’s out of the water —
and that drug got Immunomedics bought out for $21 billion.
(That’s $88 a share. Let that sink in.)

So why 25¢?

Because the market still sees the scars.
Because Wall Street forgot to check the chart that actually matters:

???? Survival. In stage 4. No evidence of disease. 36+ months and counting.

This isn’t another hype cycle.
It’s the moment the science starts speaking louder than the past.

CytoDyn isn’t loud anymore.
But it might be about to get undeniable.

48 days.
Long-term survival.
Functional remission in the deadliest breast cancer subtype.
And an OTC stock nobody’s watching.

That’s not a gamble.
That’s a setup.

And I’m betting the f*ing farm.**

Good post from a big man named Tiny on Reddit